[{"notes_id":"1_1180","category":"1","subcategory":"1","title":"Atrial fibrillation: post-stroke","body":"Atrial fibrillation is one of the key risk factors for ischaemic stroke. It is therefore very important to recognise and treat atrial fibrillation if it's identified in a patient following a stroke or transient ischaemic attack (TIA).<br \/><br \/>Management<br \/><ul><li>following a stroke or TIA it is obviously important to exclude a haemorrhage before starting any anticoagulation or antiplatelet therapy<\/li><li>for longer-term stroke prevention, NICE recommend <span class=\"concept\" data-cid=\"9732\">warfarin or a direct thrombin or factor Xa inhibitor<\/span><\/li><li>the timing of when to start depends on whether it is a TIA or stroke<ul><li><span class=\"concept\" data-cid=\"11842\">following a TIA, anticoagulation for AF should start immediately<\/span> once imaging has excluded haemorrhage<\/li><li>in acute stroke patients, in the absence of haemorrhage, <span class=\"concept\" data-cid=\"9733\">anticoagulation therapy should be commenced after 2 weeks<\/span>. Antiplatelet therapy should be given in the intervening period. If imaging shows a very large cerebral infarction then the initiation of anticoagulation should be delayed<\/li><\/ul><\/li><\/ul>","notes_hash":"fba71f642a42c2d4987e56e366b61c35","knowledge_graph_node_id_link":1162,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2041\" data-linkid=\"2041\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_2041\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13<\/span><button type=\"button\" style=\"\" id=\"link_dislike_2041\" data-linkid=\"2041\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_2041\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">28<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng196\/chapter\/Recommendations\">2021 Atrial fibrillation guidelines<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":{"9732":{"concept_text":"If a patient with AF has a stroke or TIA, the anticoagulant of choice should be warfarin or a direct thrombin or factor Xa inhibitor","concept_percentile":"75"},"9733":{"concept_text":"A patient with AF + an acute stroke (not haemorrhagic) should have anticoagulation therapy started two weeks after the event","concept_percentile":"97"}},"category_name":"Cardiovascular","subcategory_name":"Cardiology","comment_count":15},"",[]]